Key result
NPYR1 knockdown reduces myocardial fibrosis and improves functional recovery after I/R injury.
Why the study?
The role of neuropeptide Y in the pathophysiology after reperfusion in ischemic heart disease remains unanswered.
Does NPYR1 knockdown reduce myocardial fibrosis and improve cardiac function in a mouse model of myocardial ischemia/reperfusion injury?
Does NPYR1 knockdown reduce myocardial fibrosis and improve cardiac function in a mouse model of myocardial ischemia/reperfusion injury?
p-value: p=<0.01
Knockdown of NPYR1 attenuates myocardial fibrosis and improves cardiac function following ischemia/reperfusion injury, highlighting NPYR1 as a potential therapeutic target for post-MI remodeling.
NPYR1 modulation alters post-I/R fibrosis in mice; leaves open therapeutic translation to human myocardial remodeling.
Although the treatment of ischemic heart disease is becoming increasingly mature, the role of neuropeptide Y (NPY) in the pathophysiology after reperfusion still remains remains unanswered. In our study, we used a mouse model of myocardial ischemia/reperfusion (I/R) injury and demonstrated significant upregulation of NPY and its receptor NPYR1 after reperfusion. Over-expression of NPYR1exacerbates cardiac remodeling, manifested as worsening myocardial fibrosis (p < 0.01) and impaired left ventricular ejection fraction. On the contrary, NPYR1 knockdown weakened fibrosis response and improved cardiac function recovery. These findings were confirmed in HL-1 cell line subjected to hypoxia/reoxygenation model, where fibrotic markers of cardiomyocyte were similarly influenced by NPYR1 modulation. Our research findings indicate that NPY/NPYR1 signaling plays a pivotal role in maladaptive cardiac remodeling post I/R injury and is a promising therapeutic target for alleviating excessive fibrosis.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied Myocardial ischemia/reperfusion injury (n=40). NPYR1 knockdown or over-expression vs. Sham surgery or negative control virus was evaluated on Myocardial fibrosis (p=<0.01). Over-expression of NPYR1 exacerbates cardiac remodeling and worsens myocardial fibrosis (p < 0.01), whereas NPYR1 knockdown weakens the fibrosis response and improves cardiac function recovery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: